Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 2
2004 3
2005 2
2006 1
2010 1
2011 2
2012 3
2014 1
2015 2
2016 3
2017 1
2018 2
2019 3
2020 3
2021 4
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Consequences of Sarcoidosis.
Drent M, Strookappe B, Hoitsma E, De Vries J. Drent M, et al. Among authors: hoitsma e. Clin Chest Med. 2015 Dec;36(4):727-37. doi: 10.1016/j.ccm.2015.08.013. Epub 2015 Sep 26. Clin Chest Med. 2015. PMID: 26593145 Review.
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.
Toorop AA, van Kempen ZLE, Steenhuis M, Nielsen J, Sinnige LGF, van Dijk G, Roosendaal CM, Arnoldus EPJ, Hoitsma E, Lissenberg-Witte BI, de Jong BA, Oosten BWV, Strijbis EMM, Uitdehaag BMJ, Rispens T, Killestein J; NEXT-MS study group. Toorop AA, et al. Among authors: hoitsma e. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):482-486. doi: 10.1136/jnnp-2022-330467. Epub 2023 Jan 13. J Neurol Neurosurg Psychiatry. 2023. PMID: 36639226
Neurosarcoidosis: a clinical dilemma.
Hoitsma E, Faber CG, Drent M, Sharma OP. Hoitsma E, et al. Lancet Neurol. 2004 Jul;3(7):397-407. doi: 10.1016/S1474-4422(04)00805-1. Lancet Neurol. 2004. PMID: 15207796 Review.
COVID-19 in multiple sclerosis: The Dutch experience.
Loonstra FC, Hoitsma E, van Kempen ZL, Killestein J, Mostert JP. Loonstra FC, et al. Among authors: hoitsma e. Mult Scler. 2020 Sep;26(10):1256-1260. doi: 10.1177/1352458520942198. Epub 2020 Jul 14. Mult Scler. 2020. PMID: 32662742 Free PMC article.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
Toorop AA, van Lierop ZY, Gelissen LM, Hoitsma E, Zeinstra EM, van Rooij LC, van Munster CE, Vennegoor A, Mostert JP, Wokke BH, Kalkers NF, Hoogervorst EL, van Eijk JJ, Roosendaal CM, Kragt JJ, Eurelings M, van Genugten J, Nielsen J, Sinnige L, Kloosterziel ME, Arnoldus EP, van Dijk GW, Bouvy WH, Wessels MH, Boonkamp L, Strijbis EM, van Oosten BW, De Jong BA, Lissenberg-Witte BI, Barkhof F, Moraal B, Teunissen CE, Rispens T, Uitdehaag BM, Killestein J, van Kempen ZL. Toorop AA, et al. Among authors: hoitsma e. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):392-400. doi: 10.1136/jnnp-2023-332119. J Neurol Neurosurg Psychiatry. 2024. PMID: 37963723 Clinical Trial.
Outcome of Carpal Tunnel Release and the Relation With Depression.
Datema M, Tannemaat MR, Hoitsma E, van Zwet EW, Smits F, van Dijk JG, Malessy MJA. Datema M, et al. Among authors: hoitsma e. J Hand Surg Am. 2018 Jan;43(1):16-23. doi: 10.1016/j.jhsa.2017.08.020. Epub 2017 Sep 23. J Hand Surg Am. 2018. PMID: 28951099
36 results